Table 1 Clinico-demographic characteristics of the patients with esophageal cancer
Variable | N (%) |
|---|---|
Gender | |
Male | 50 (60.24) |
Female | 33 (39.76) |
Age distribution | |
21 – 30 | 1 (1.20) |
31 – 40 | 5 (6.02) |
41 – 50 | 15 (18.07) |
51 – 60 | 22 (26.51) |
61 – 70 | 28 (33.73) |
71 – 80 | 9 (10.84) |
81 – 90 | 3 (3.61) |
Histology | |
Squamous cell carcinoma | 67 (80.72) |
Adenocarcinoma | 12 (14.46) |
Dysplasia | 2 (2.41) |
Gastrointestinal stromal tumor | 1 (1.20) |
Lymphoma | 1 (1.20) |
Site of cancer | |
Middle third | 50 (60.24) |
Lower third | 20 (24.10) |
Gastroesophageal junction | 13 (15.66) |
TNM stage of tumor | |
High-grade dysplasia | 2 (2.41) |
I | 8 (9.64) |
II | 64 (77.11) |
III | 9 (10.84) |
ASA grading | |
I | 2 (2.41) |
II | 60 (72.29) |
III | 19 (22.89) |
IV | 2 (2.41) |
Preoperative morbidity | |
Diabetes mellitus | 11 (13.25) |
Bronchial asthma | 3 (3.61) |
Hypertension | 15 (18.07) |
Stroke | 1 (1.20) |
Ischemic heart disease | 2 (2.41) |
Hemiplagia | 1 (1.20) |